284 related articles for article (PubMed ID: 10426675)
1. Use of the disutility ratio in prenatal screening for Down's syndrome.
van der Meulen JH; Mol BW; Pajkrt E; van Lith JM; Voorn W
Br J Obstet Gynaecol; 1999 Feb; 106(2):108-15. PubMed ID: 10426675
[TBL] [Abstract][Full Text] [Related]
2. Using decision analysis to compare policies for antenatal screening for Down's syndrome.
Fletcher J; Hicks NR; Kay JD; Boyd PA
BMJ; 1995 Aug; 311(7001):351-6. PubMed ID: 7640539
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
4. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
[TBL] [Abstract][Full Text] [Related]
5. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia.
Cheffins T; Chan A; Haan EA; Ranieri E; Ryall RG; Keane RJ; Byron-Scott R; Scott H; Gjerde EM; Nguyen AM; Ford JH; Sykes S
BJOG; 2000 Dec; 107(12):1453-9. PubMed ID: 11192100
[TBL] [Abstract][Full Text] [Related]
6. Antenatal screening for Down's syndrome.
Wald NJ; Kennard A; Hackshaw A; McGuire A
J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
[TBL] [Abstract][Full Text] [Related]
7. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
Wald NJ; Kennard A; Densem JW; Cuckle HS; Chard T; Butler L
BMJ; 1992 Aug; 305(6850):391-4. PubMed ID: 1382768
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.
Spencer K; Carpenter P
BMJ; 1993 Sep; 307(6907):764-9. PubMed ID: 7693095
[TBL] [Abstract][Full Text] [Related]
9. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
[TBL] [Abstract][Full Text] [Related]
10. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
11. Strategies for antenatal detection of Down's syndrome.
Wyllie JP; Madar RJ; Wright M; Burn J; Wren C
Arch Dis Child Fetal Neonatal Ed; 1997 Jan; 76(1):F26-30. PubMed ID: 9059182
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
Khoshnood B; Pryde P; Blondel B; Lee KS
Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
[TBL] [Abstract][Full Text] [Related]
13. Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level.
Tabor A; Larsen SO; Nielsen J; Nielsen J; Philip J; Pilgaard B; Videbech P; Nørgaard-Pedersen B
Br J Obstet Gynaecol; 1987 Jul; 94(7):636-42. PubMed ID: 2441737
[TBL] [Abstract][Full Text] [Related]
14. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
15. Acceptance of amniocentesis by women in the state of Montana (USA) who are screen positive for Down's syndrome.
Priest JH; FitzGerald JM; Haag MM; Streets K; Vanisko M; Johnson JP
J Med Screen; 1998; 5(4):178-82. PubMed ID: 9934647
[TBL] [Abstract][Full Text] [Related]
16. Down's syndrome: current screening techniques.
White RS
South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
[TBL] [Abstract][Full Text] [Related]
17. Down's syndrome screening: a controversial test, with more controversy to come!
Reynolds TM
J Clin Pathol; 2000 Dec; 53(12):893-8. PubMed ID: 11265172
[TBL] [Abstract][Full Text] [Related]
18. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
[TBL] [Abstract][Full Text] [Related]
19. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
Leporrier N; Herrou M; Morello R; Leymarie P
BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
[TBL] [Abstract][Full Text] [Related]
20. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
